Todd Gordon, founder of Inside Edge Capital, joins CNBC's 'Power Lunch' to discuss why he's keeping an eye on shares of these ...

After their grandmother's death, two cousins are arguing over who is the rightful owner of their loved one's bling — and it's ...

And so Lively is game to method dress for any movie—even if it isn’t hers.

The partnership between Ro and Eli Lilly (LLY) to streamline access to Lilly’s GLP-1 Zepbound single-dose vials for Ro patients with obesity is ...

BofA analyst Allen Lutz notes Ro Health, a direct competitor to Hims & Hers (HIMS), announced that the company is working with Eli Lilly ...

Eli Lily continues to dominate the weight loss market, willing to crush any competitor that threatens its dominance.

Shares of Hims & Hers Health Inc. slid to a three-week low on Wednesday before recovering some losses, even as retail ...

Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.87 which represents a decrease of $-1.76 or -5.39% from the prior close of $32.63. The stock opened at $32.25 and touched a low ...

Martha Stewart has built an empire teaching audiences about everything from cooking to gardening, but what are her favorite ...

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

Hims & Hers Health is financially strong with minimal debt and a dominant market share. Find out what makes HIMS stock a ...

A woman on Reddit seeks advice when she learns that the child she had with her husband via surrogate isn't biologically her ...